Advanced Search

Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2006 December;58(6) > Minerva Ginecologica 2006 December;58(6):489-97

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index

 

Minerva Ginecologica 2006 December;58(6):489-97

 REVIEWS

Ovulation induction in anovulatory women

La Marca A., Bertucci E., Giulini S., Tirelli A., Malavasi B., Volpe A.

Sezione di Ginecologia e Ostetricia Dipartimento Materno Infantile Università degli Studi di Modena e Reggio Emilia, Modena

Ovulation induction therapy is administered to stimulate follicular growth and induce ovulation in anovulatory infertile women. In anovulatory women with polycystic ovary syndrome, the treatment of choice is clomiphene citrate, whereas in clomiphene nonresponders, gonadotrophins are given as secondary therapy. Currently, insulin-sensitizing agents are used in the treatment of polycystic ovary syndrome to restore menstrual cyclicity. In selected patients, laparoscopic drilling has also been suggested. In anovulatory patients affected with hypogonadotropic hypogonadism, treatment is based on gonadotrophin replacement therapy or pulsatile gonadotrophin-releasing hormone infusion. In ovulation induction therapy the clinician’s attention should be directed at restoring normal ovary function. When pharmacotherapy is required, monofollicular growth should be induced to reduce the risk of multiple pregnancy.

language: Italian


FULL TEXT  REPRINTS

top of page